Herceptin Clinical Study
Links shared publicly online about this topic
Cancer study backs Roche's Herceptin with chemo | Reuters
reuters.com — “* Herceptin suited to many advanced, inflammatory cancers * Study finds drug works well combined with chemotherapy By Kate Kelland LONDON, Jan 29 (Reuters) - Roche's cancer drug Herceptin” View full resource at reuters.com
Most Recently Shared on January 30, 2010 at 1:15 pm By:
Study: Herceptin with chemotherapy outperforms chemotherapy alone in subgroup of patients with breast cancer. http://tinyurl.com/ya5q3zz
Mathematical modeling predicts response to Herceptin
physorg.com — “Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new paper in Cancer Research, a journal of the American Association for Cancer Research, illustrates how the technique may answer questions about Herceptin resistance.” View full resource at physorg.com
Most Recently Shared on July 28, 2009 at 8:18 pm By:
Mathematical modeling predicts response to Herceptin http://bit.ly/z80ha
Mathematical Modeling Predicts Response To Herceptin
feeds.sciencedaily.com — “Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new article illustrates how the technique may answer questions about Herceptin resistance.” View full resource at feeds.sciencedaily.com
Most Recently Shared on August 4, 2009 at 1:23 pm By:
Mathematical Modeling Predicts Response To Herceptin: Cancer researchers are turning to mathematical models to h.. http://bit.ly/e1FLn
Herceptin And Tykerb Effective Against A Subset Of Gastric Cancers
medicalnewstoday.com — “A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a” View full resource at medicalnewstoday.com
Most Recently Shared on March 3, 2010 at 7:13 pm By:
MNT Gastrointestinal Health News
Herceptin And Tykerb Effective Against A Subset Of Gastric Cancers http://mnt.to/3ypT #gastrointestinal
Study: Give Herceptin at Same Time as Chemo - Tom Heston
tomheston.com — “Study: Give Herceptin at Same Time as Chemo - Tom Heston” View full resource at tomheston.com
Most Recently Shared on December 17, 2009 at 1:00 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Study: Give Herceptin at Same Time as Chemo http://bit.ly/6gwYtQ
Herceptin extends life of patients with terminal stomach cancer, study finds
physorg.com — “(PhysOrg.com) -- Breast cancer drug Herceptin can extend the lives of patients with incurable stomach cancer by nearly three months, according to an international study involving researchers from the University of Glasgow.” View full resource at physorg.com
Most Recently Shared on June 1, 2009 at 8:25 pm By:
Herceptin extends life of patients with terminal stomach cancer, study finds http://tinyurl.com/lq4dby
Study shows use of Herceptin in treatment of stomach cancer prolongs life
physorg.com — “(PhysOrg.com) -- A study involving a University of Glasgow cancer specialist has found that using Herceptin increases survival rates among those with stomach cancer.” View full resource at physorg.com
Most Recently Shared on September 25, 2009 at 6:07 pm By:
Study shows use of Herceptin in treatment of stomach cancer prolongs life http://bit.ly/AdLAD
Phase 3 Study of Pertuzumab with Herceptin for Breast Cancer - ONA
oncologynurseadvisor.com — “Genentech announced results from its Phase 3 CLEOPATRA study of pertuzumab and trastuzumab (Herceptin; Genentech) plus docetaxel chemotherapy for the treatment of patients with HER2-positive metastatic breast cancer (mBC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 15, 2011 at 3:05 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Pertuzumab with Herceptin for Breast Cancer http://goo.gl/fb/dxIgZ
Mayo Clinic - Mayo Clinic Researchers say Disease-Free Breast Cancer Survival Improves When Herceptin is Used With Chemotherapy
mayoclinic.org — “Mayo Clinic - Mayo Clinic Researchers say Disease-Free Breast Cancer Survival Improves When Herceptin is Used With Chemotherapy” View full resource at mayoclinic.org
Most Recently Shared on December 16, 2009 at 8:28 am By:
Mayo Clinic Researchers say Disease-Free Breast Cancer Survival Improves When Herceptin is Used... http://bit.ly/7BiRnv from Mayo Clinic FL
Phase 3 Study of Pertuzumab with Herceptin for Breast Cancer - MPR
empr.com — “Genentech announced results from its Phase 3 CLEOPATRA study of pertuzumab and trastuzumab (Herceptin; Genentech) plus docetaxel chemotherapy for the treatment of patients with HER2-positive metastatic breast cancer (mBC).” View full resource at empr.com
Most Recently Shared on July 15, 2011 at 3:52 pm By:
MPR News: Phase 3 Study of Pertuzumab with Herceptin for Breast Cancer: Genentech announced results from its Pha... http://bit.ly/qDLWrn
Targeted Agent Addition to Herceptin Has Positive Effect on Metastatic HER-2 Breast Cancer
newswise.com — “Adding Afinitor® to Herceptin®, the main treatment for HER2-positive metastatic breast cancer, helps some women with disease that has been resistant to previous Herceptin-based therapies, according to a study led by researchers at The University of Texas MD Anderson Cancer Center and published in the Journal of Clinical Oncology.” View full resource at newswise.com
Most Recently Shared on July 8, 2011 at 9:13 pm By:
Targeted Agent Addition to Herceptin Has Positive Effect on Metastatic HER-2 Breast Cancer: Adding Afini... http://bit.ly/oCvjK2 #cancer
Targeted Agent Addition to Herceptin Has Positive Effect on Metastatic HER-2 Breast Cancer
newswise.com — “Adding Afinitor® to Herceptin®, the main treatment for HER2-positive metastatic breast cancer, helps some women with disease that has been resistant to previous Herceptin-based therapies, according to a study led by researchers at The University of Texas MD Anderson Cancer Center and published in the Journal of Clinical Oncology.” View full resource at newswise.com
Most Recently Shared on July 8, 2011 at 9:39 pm By:
#health news: Targeted Agent Addition to Herceptin Has Positive Effect on Metastatic HER-2 Breast Cancer: Adding... http://bit.ly/qym513
Afinitor shows potential to reverse resistance to Herceptin[*] in metastatic breast cancer patients, leading to Phase III trial
novartis.com — “Basel, December 12, 2008 - New data from two early clinical studies show that Afinitor (everolimus) may overcome resistance to Herceptin (trastuzumab)[*] in women with HER2- positive metastatic breast cancer[1],[2]. These results support the initiation of a Phase III clinical trial program to fully explore the potential of Afinitor, also known as RAD001, in breast cancer.” View full resource at novartis.com
Most Recently Shared on December 12, 2008 at 11:22 pm By:
Afinitor® shows potential to reverse resistance to Herceptin®[*] in metastatic breast cancer patients, leading t.. http://twurl.nl/w5kicj
Routine Testing Would Improve Herceptin Use in Breast Cancer
health.msn.com — “Routine Testing Would Improve Herceptin Use in Breast Cancer” View full resource at health.msn.com
Most Recently Shared on September 14, 2009 at 3:49 pm By:
Routine Testing Would Improve Herceptin Use in Breast Cancer http://bit.ly/3Lpcg3
45% Of Breast Tumors Destroyed With Pertuzumab And Herceptin Combo Plus Chemotherapy Docetaxel
medicalnewstoday.com — “45% of women with pre-surgery early-stage HER2-positive breast cancer experienced a complete tumor reduction when given Pertuzumab and Herceptin plus chemotherapy (docetaxel) during a Phase II stu” View full resource at medicalnewstoday.com
Most Recently Shared on December 10, 2010 at 8:24 pm By:
45% Of Breast Tumors Destroyed With Pertuzumab And Herceptin Combo Plus Chemotherapy Docetaxel http://mnt.to/3NX3 #healthnews
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
-
sciencedaily
Visit ScienceDaily to read breaking news about the latest discoveries in science, health, the environment, and technology.
Advertisement
